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Appropriate treatment options for early colorectal cancer 
(ECRC) smaller than 20 mm remains controversial. Here, we 
studied the efficacy and safety of endoscopic therapy for ECRC 
smaller than 20 mm. About 191 patients with colorectal lesions 
entered into our study from January 2017 to December 2019. 
Lesions were divided into two groups according to sizes: smaller 
than 10 mm group and 10-20 mm group. Most cases of ECRC 
were found in the left colon (70.15%), and the male to female 
ratio was 1.81:1. A very smaller proportion of colorectal lesions 
smaller than 10 mm in size were submucosal carcinoma (0.077%), 
whereas 3.85% of colorectal lesions between 10 mm and 20 mm 
in size were submucosal carcinoma (P=0.049). Cold snare 
polypectomy (CSP) was found to be a safe and efficient for 
lesions smaller than 10 mm. For the lesions smaller than 10 mm, 
the rate of en bloc resection reached 100%, whereas only 81.82% 
of the lesions of 10-20 mm in size could be resected en bloc and 
for these cases, endoscopic mucosal resection (EMR) were better 
therapeutic options. Endoscopic CSP is an appropriate therapeutic 
approach for ECRC of less than 10 mm in size, whereas for 
lesions smaller than 10 mm in size but with submucosal 
infiltration, EMR should be considered. For submucosal 
carcinoma (SM-carcinoma), endoscopic submucosal dissection 
(ESD) or surgery should be considered as better options.  
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Colorectal cancer (CRC) is one of the most common 
malignant tumors affecting 1.93 million people all 
over the world1. In China too, incidence, morbidity 
and mortality of colorectal cancer have increased over 
the recent years2,3. In China Cancer Statistics, CRC 
ranks fifth among all malignant tumors in terms of 
incidence and mortality with a total of 376,000 new 
cases and 191,000 deaths in 2015, hence constituting 
a serious health threat to the society2. Early diagnosis 
and early treatment are key determinants for the 
prognosis of CRC4-6. Early CRC can be cured and a 
5-year survival rate of up to 90% can be achieved,
while the patients with advanced CRC often show
a poor 5-year survival rate of <10%7-10. Early colorectal
cancer (ECRC) is defined as colorectal cancer confined
to the mucosa or submucosa irrespective of the
presence of regional lymph node metastasis4. Surgery
is the mainstay in the management of CRC.
In recent years, endoscopic resection has been 
proven to be an effective therapeutic method for 
precancerous lesions and ECRC. Commonly used 
endoscopic techniques include Cold snare polypectomy 
(CSP), Endoscopic mucosal resection (EMR), and 
endoscopic submucosal dissection (ESD) 11,12. Most of 
the small adenomas and early cancers in gastro-
intestinal tract can be easily removed by CSP or 
EMR13,14. However, CSP and EMR may not always 
be available and large tumors may be difficult to 
remove by these techniques. As such, local recurrence 
after resection by CSP or EMR may occur15-17. 
Consequently, ESD was developed in the late 1990s 
in Japan but it was then considered too risky at 
that time because this technique was often associated 
with severe complications such as perforation and 
bleeding. According to the 2017 Guidelines of 
European Society of Gastrointestinal Endoscopy 
(ESGE), whole removal technique including EMR, 
ESD and surgery should be used for superficial 
invasive tumors18, whereas cold and hot trap removal 
should be used for lesions<20 mm15-18. 
We present here our investigation on the efficacy and 
safety of endoscopic therapy for ECRC smaller than 
20 mm with 191 patients with colorectal lesions entered 
into our study from January 2017 to December 2019.  
Subjects and Methods  
A total of 191 consecutive patients with 201 
colorectal lesions of less than 20 mm in size, 
including high-grade dysplasia (n=110) and ECRC 
(n=91), who undertook CSP, EMR or ESD from 
January 2017 to December 2019 in the Digestive 
Endoscopy Center of Beijing Shijitan Hospital 
Affiliated to the Capital Medical University, Beijing 
China, were included in this retrospective study. 
Patients were divided into two groups according to 
the size of the lesions: Group I: those with lesion sizes 
10 mm; and Group II: those with lesion sizes between 








invasive carcinoma, inflammatory bowel disease 
(IBD), intestinal tuberculosis, familial adenomatous 
polyposis (FAP), other invasive carcinomas and 
circumferential tumors requiring surgical resection or 
incomplete pathological data were excluded from this 
study. The clinicopathological information including 
gender, age, lesion site, endoscopic features, operation 
method, postoperative pathological features and 
postoperative complications (including bleeding, 
perforation, and infection) were collected. All patients 
were informed of the risks and benefits of CSP, EMR 
and ESD, and written consent from each patient was 
obtained. The study was approved by the Human Ethics 
Committee of the Beijing Capital Medical University.  
 
Procedures, pre- and post-operative management  
Anticoagulant and antiplatelet drugs, if any, were 
discontinued at least seven days before the CSP, EMR 
and ESD procedures. In addition, narrow band imaging 
(NBI) endoscopy was performed to assess the lesion 
sizes prior to the CSP, EMR and ESD procedures. 
 
Cold snare polypectomy (CSP) 
CSP is suitable for the treatment of small colorectal 
polyps because of its shorter procedure time and 
lower rate of delayed bleeding than HSP or EMR. The 
“pull technique” was used where polyp is ensnared, 
pulled into the colonoscope channel and transected 
with simultaneous suctioning19-21. 
 
Endoscopic mucosal resection (EMR) 
The key procedures for EMR include submucosal 
injection to make protrusion and snaring of protruded 
area. Generally, 10% glycerin solution or hyaluronic 
acid solution is injected underneath the submucosa to 
form a fluid cushion that lifts the target lesions. The 
elevated lesions can then be captured by snare and 
removed without excessive thermal damage on both 
muscle layer and the specimen22-24. 
 
Endoscopic submucosal dissection (ESD) 
ESD was performed with the patient under general 
intravenous anesthesia and constant monitoring of 
cardiopulmonary functions (heart rate, blood pressure, 
and oxygen saturation). Five mL of solution 
containing 5% indigo carmine and 1% epinephrine is 
injected underneath the submucosa using a 23-guage 
disposable needle and a mucosal incision is created 
along the normal mucosa approximately 5 mm away 
from the tumor. Next, a hook knife or SB-knife was 
used to dissect the submucosal connective tissues 
beneath the tumor. During the dissection, the solution 
was injected repeatedly when necessary. At the 
completion of the resection, all visible vessels of the 
artificial ulcer bed were thoroughly coagulated with 




After removing the lesions, specimens were 
retrieved with forceps or basket. The margins were 
carefully investigated to ensure complete lesion 
resection before completing the operation. Hemostatic 
forceps or metal clips were used to manage 
intraoperative bleeding. Delayed bleeding as defined 
by significant blood loss (>3 units) was treated with 
endoscopic hemostasis. Patients without adverse 
events were permitted to drinking water the first day 
and eating soft food on the second day after the 
operation. Generally, patients can start the normal 
diets on postoperative days 4 or 5.  
An en bloc resection was defined as an excision of 
the tumor in one piece without fragmentation. The 
resected specimens were carefully examined. Based on 
the Guidelines of the Japanese Society for Cancer of 
colon and rectum (JSCCR)28, a histological complete 
resection was defined as an en bloc resection with 
negative horizontal and vertical margins, and a R0 
resection was defined as a histological complete 
resection without lymph node metastasis. 
 
Definition of complications 
Intraoperative complications were assumed if there 
was clinical evidence during the procedure (for 
examples, transmural cut for perforation, and massive 
bleeding). The delayed bleeding was defined as 
significant blood loss of three hemoglobin units after 
completion of the ESD procedure29. 
 
Statistical analysis 
Statistical analysis was performed using SPSS 
Version 21.0/IBM. All measurement data of normal 
distribution were expressed as x±s, and the counting 
data were expressed as the composition ratio and rate. 
A χ2 test or continuous correction χ2 test was used to 
analyze the bidirectional unordered R×C comparisons 
between groups. A P value of <0.05 or <Bonferroni 
adjusted value was considered statistically significant. 
 
Results 
The baseline and clinicopathological characteristics 
of the patients are summarized in Table 1. Among the 
22,067 patients undertook colonoscopy between 
January 2017 and December 2019. About 191 cases 
(including 123 male and 68 females, median age 13±6 
years) had a total of 201 colonic tumors. Among these 
tumors, 67 were smaller than 10 mm (Gr. I) and 134 




were between 10 mm to 20 mm (Gr. II). There were 
67 cases in Gr. I, including 39 male children (58.21%) 
and 28 female (41.79%), with a mean age of 13.4±6.6 
years. The median tumor size was 7.0±1.6 mm.  
More than 64.2% of the tumors were found in the left 
colon (n=43) and the rest were in the right colon 
(n=24, 35.8%). There were 134 cases in Gr. II, 
including 84 male (62.7%) and 50 females (37.3%), 
with a mean age of 14.8±5.2 years. The median tumor 
size was 14.8±4.1 mm. Similar to Gr. I, the majority 
of the tumors were located in the left colon (n=98, 
73.1%) and a smaller proportion of the tumors were 
found in the right colon (n=36, 26.9%).  
 
As shown in Table 1, males had a higher incidence 
rate of ECRC than females, and more of the colonic 
tumors were found in the left colon, while only 
approximately one third of the cases were found in the 
right colon. No significant difference in the age, sex, 
and the anatomic location of the lesions was found 
between the two groups.  
 
Endoscopic findings 
The colonic lesions were classified into Ip, Is, Isp, 
IIa, IIb, IIc and LSTs, as per the guidelines of the 
Paris Classification as given below: Ip, Pedunculated; 
Isp, Semi-pedunculated; Is, Sessile, higher than height 
of closed forceps (2.5 mm); IIa, Slightly elevated, 
below height of closed forceps (2.5 mm); IIb, 
Completely flat lesion, does not protrude above 
mucosal surface; and IIc, Slightly depressed, lower 
than mucosa but depth less than 1.2 mm. Among the 
67 cases in Gr. I, 17 cases had Ip lesions (25.4%); 
another 17 cases had Isp lesions (25.4%); 13 cases 
had Is lesions (19.4%); and 20 cases had IIa lesions 
(29.8%). IIa lesions were more common in Gr. I  
than in Gr. II (29.8% vs. 5.2%, P <0.01). Among the  
134 cases in Gr. II, 52 cases had Ip lesions (38.8%); 
36 cases, Isp lesions (26.9%); 24 cases, Is lesions 
(17.9%); 7 cases, IIa lesions (5.2%); and 15 cases had 
LST lesions (15, 11.2%). Ip lesions were more 
common in Gr. II than in Gr. I (38.8% vs. 25.4%,  
P 0.<01), and LST lesions were more common in  
Gr. II than in Gr. I (11.2% vs. 0.0%, P <0.01)  
(Table 2). 
Efficacy and safety 
In Gr. I, three cases had Is, Isp, and IIa lesions 
respectively, and the size of these lesions were 4-6 mm. 
Upon biopsy resection and histopathology, these 
lesions were found to be high-grade dysplasia. 
Among the 17 cases receiving CSP, and the lesions 
were IIa (n=9) or Is (n=8), and histopathology all 
revealed high-grade dysplasia. Among the 47 cases 
undertaking EMR, 23 cases had high-grade dysplasia, 
another 23 cases had mucosal carcinoma (M-
carcinoma), and one case had submucosal carcinoma 
(SM-carcinoma). All lesions were of 5-10 mm in size. 
Of special note, the 6 mm SM-carcinoma was a type 
IIa lesion, with depression on the surface, acanthosis 
at the base, and an infiltration depth of 600 um but 
clear vertical and lateral margins. No complications 
such as bleeding, perforation and infection occurred 
immediately after and 3-6-month post the endoscopic 
procedures. Our data indicated that SM-carcinoma of 
<10 mm was rare, and the infiltration depth was rarely 
deeper than 1000 m. Overall, CSP and EMR were 
effective and safe procedures for the treatment of 
colonic lesions of 10 mm. 
In Gr. I, eleven cases received CSP and the lesions 
were high-grade dysplasia (n=9) or M-carcinoma 
Table 1 — Characteristics seen in colonoscopy 
Variable Tumor size 
<10 mm (n=67) 
Tumor size 
























10 mm (n=67) 
Tumor size 
10-20 mm (n=134) 
P 
value 
Age (year) 13.4±6.6 4.8±5.2  0.849 
Gender ratio (M:F) 39/28 84/50 0.443 
Mean size (mm) 7.0±1.6 14.8±4.1  
Location ratio 
(Left/Right) 
43/24 98/36 0.127 
Characteristics    
Ip 17 (25.4%) 52 (38.8%)  <0.01 
Isp 17 (25.4%) 36 (26.9%) 0.199 
Is 13 (19.4%) 24 (17.9%) 0.110 
IIa 20 (29.8%) 7 (5.2%) <0.01 
LST 0 (0%) 15 (11.2%) <0.01 
Treatment options    
Biopsy 3 (4.5%) 0 (0%) <0.01 
CSP 17 (25.4%) 11 (8.2%) <0.01 
EMR 47 (70.1%) 97 (72.4%) 0.172 
ESD 0 (0%) 26 (19.4%) <0.01 
Complications    
Perforation 0 (0%) 0 (0%)  
Bleeding 0 (0%) 2 (1.5%)  
Infection 0 (0%) 0 (0%)  
Histology    
HG-IEN 43 (64.2%)  67 (50.0%) 0.143 
M-Carcinoma 23 (34.3%) 62 (46.3%) 0.135 
SM-Carcinoma 1 (1.5%) 5 (3.7%) 0.049 
Completed procedures    
En bloc resection 67 (100%) 129 (98.5%) 0.128 
 




(n=2). Among which two cases had positive vertical 
and lateral margins. EMR was performed in 108 
cases. Histopathologically, most of them were type I 
lesions (n=82), two had SM-carcinoma (including one 
Isp lesion with expansive appearance, and one Is 
lesion with fold convergence). The lesions invaded 
into the submucosal tissues by 760 m and 800 m, 
respectively and the vertical and lateral margins were 
all positive. These two lesions were treated with 
surgery after endoscopic therapy. Twenty-six cases 
were treated with ESD (including 11 cases with LST 
lesion, 13 cases with Is lesion, and two cases with IIa 
lesion). In three cases, surgery was performed one 
week after endoscopic treatment because of 
submucosal infiltration and incomplete resection. 
Two cases with Is lesion had depressed area 
endoscopically and by histopathology, the lesions 
were SM-carcinoma with an invasion depth of 1000 m. 
One case had IIa lesion with erosion and expansive 
appearance, and histopathologically, moderately to 
poorly differentiated adenocarcinoma with an 
invasion depth of 700 m was revealed. In this case, 
the vertical and lateral margins were all negative. Two 
cases (1.49%) occurred post procedure bleeding who 
were treated with coagulation therapy. Overall, SM-
carcinoma was more common in Gr. II than in Gr. I 
(P＝0.049), ESD was more common in Gr. II than in 
Gr. I (P <0.01), CSP was less common in Gr. II than 
in Gr. I (P <0.01). 
 
Discussion 
Our study has shown that most of the ECRC are in 
the left colon. Consistent with the published data30,31, 
these lesions are more common in men than in women 
with a male to female ratio of 1.81:1. Lesion size is an 
important indicator for the invasion depth and a key 
determinant for selecting the treatment approach for 
advanced colorectal neoplasms32,33. It was previously 
reported that 7.4-14% of colorectal polyps larger  
than 20 mm were SM-carcinoma32-35, whereas others 
reported that only 0.07 to 5.8% of the polyps less than 
20 mm were SM-carcinoma34,35. In our study, 0.08% 
of polyps smaller than 10 mm in size were SM-
carcinoma and 3.9% of polyps between 10 and 20 mm 
in size were SM-carcinoma. These characteristics are 
consistent with what have been reported by others32-35. 
It shows that tumors of small size are still possibly be 
SM-carcinoma. The reported morphological features 
of SM-carcinoma include loss of normal lobulation, 
excavation (a crumbled, damaged area of the tumor 
that may prevent observation of the surface structure), 
demarcated depression (depressed demarcations on 
the tumor surface), stalk swelling (a thickened and 
expanded stalk), fullness (a bursting appearance due 
to expansive growth of the tumor), fold convergence 
towards the tumor, bleeding ulcers, pit patterns and 
non-lifting signs33-35. The pit pattern is further divided 
as invasive or non invasive, where invasive patterns 
are characterized by irregular and distorted crypts in 
demarcated areas, whereas non-invasive patterns are 
characterized by lesions with normal mucosa, star-
shaped crypts, or regular crypts with or without 
demarcated areas or irregular pits without demarcated 
areas. A positive non-lifting sign refers to a lesion 
where only the surrounding mucosa but not the lesion 
can be lifted following submucosal injection, whereas 
a negative non-lifting sign refers to a lesion that can 
be easily elevated32,33.  
 
An assessment of the above patterns prior to 
endoscopic therapy may provide important information 
on the tumor nature and depth of invasion. In our 
study, a case of colonic lesion smaller than 10 mm 
was found to be SM-carcinoma with a demarcated 
depression on the tumor surface. Five cases with the 
lesion size of 10-20 mm were found to be SM-
carcinoma with demarcated depression, fullness, and 
spontaneous bleeding. As per the 2017 Guideline of 
European Society of Gastrointestinal Endoscopy 
(ESGE), CSP is the treatment of choice for sessile or 
flat superficial colorectal neoplasia smaller than  
10 mm10, whereas biopsy forceps (CBF) is not 
recommended for such lesions because of high rates 
of incomplete resection. In a randomized control trial 
of CSP vs. CBF, the rate of residual neoplastic tissue 
found after polypectomy for lesions sized 5-7 mm 
was significantly lower in the CSP group than in CBF 
polypectomy group (6.2% vs. 29.7%; P=0.013)16,17. In 
our study, three cases of Is, Isp and IIa lesions with 
the sizes of 4-6 mm were treated with CBF, and  
the post-procedure pathology revealed high-grade 
dysplasia with negative vertical and lateral margins. 
Due to insufficient sample size, we were unable to 
compare the efficacy and safety of CSP, EMR, ESD. 
CSP was performed in 17 cases of lesions smaller 
than 10 mm and 11 cases of lesions 10-20 mm, two of 
these cases with pedunculated lesions had incomplete 
resection with positive lateral margins. Two of these 
cases with sessile lesions had postoperative bleeding 
which was successfully managed endoscopically. We 
felt that CSP is an adequate safe and efficient 




treatment for lesions smaller than 10 mm. For lesions 
of 10-20 mm in size, there was an increased 
possibility of incomplete resection, especially for flat 
lesions. In a retrospective study of 248 polyps sized 
10-19 mm, complete resection was achieved in 89.5% 
of cases by CSP and in 95.6% of cases by EMR. In a 
retrospective study that evaluated piecemeal CSP 
outcomes for sessile polyps of size >10 mm, 30 
lesions between 10 mm and 19 mm were completely 
retrieved without any adverse events such as delayed 
bleeding, post-polypectomy syndrome, or perforation. 
Of 27 patients who underwent follow-up colonoscopy 
within 6 months, 98.6% did not have residual 
carcinoma tissue at the resection site. For sessile or 
flat superficial colorectal neoplasia 10-19 mm, EMR 
was recommended by ESGE as a preferred treatment. 
However, for SM-carcinoma, ESD is treatment of 
choice, especially for flat, sessile and LST lesions. 
 
Conclusion 
Our data have confirmed the efficacy and safety of 
CSP for endoscopic en bloc resection of high-grade 
dysplasia and ECRC of 10 mm in size, whereas 
EMR is the preferred approach for endoscopic en bloc 
resection of high-grade dysplasia and ECRC sized  
10-20 mm but without submucosal infiltration. For 
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